Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Life Insurance

Swiss Re Securitizes Again

By staff Writer

X
Your article was successfully shared with the contacts you provided.

Swiss Reinsurance Company says it has succeeded at securitizing a substantial amount of extreme mortality risk for the third time in less than 12 months.

Swiss Re, Zurich, says it has transferred about $175 million in mortality risk through the Vita Capital IV Ltd. securitization program.

Swiss Re sold notes linked to Vita IV through a private placement.

Through the Vita IV notes, Swiss Re can get payments of up to $100 million in the event of severe mortality in the United States or Japan, and up to $75 million in the event of severe mortality in Canada or Germany.

Swiss Re sold similar batches of Vita program notes in November 2009 and May 2010. The first Vita notes securitized mortality risk in the United States and the United Kingdom, the company says.

In 2008, the credit market crisis raised questions about whether reinsurers would continue to have adequate access to investor capital.

The Vita IV program collateral consists of securities issued by the International Bank for Reconstruction and Development, Swiss Re says.

- Allison Bell

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.